Marcaine Spinal Injection, Solution
Product Images NDC 0409-1761

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Marcaine Spinal (NDC 0409-1761). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hospira Logo (Marcaine 01)

FDA Label Image

Structural Formula Bupivacaine Hydrochloride (Marcaine 02)

FDA Label Image

Structural Formula Dextrose (Marcaine 03)

FDA Label Image

Hospira Logo (Marcaine 04)

FDA Label Image

Principal Display Panel (2 mL Ampule Label)

Principal Display Panel (2 mL Ampule Label)
This is a prescription drug called Marcaine. It contains bupivacaine hydrochloride and dextrose and is used for injections. The label includes information about the drug's composition, dosage, and manufacturer.*
FDA Label Image

Principal Display Panel (2 mL Ampule Unit Dose Pak Label)

Principal Display Panel (2 mL Ampule Unit Dose Pak Label)
Description: This text includes various pieces of information, such as a product name (UNI-AMP), a unit dose package size (2mL), prescription only labeling (Rxonly), the product's national drug code (NDC 0409-1761-19), a company name (Hosprane) along with its address, a drug name (bupivacaine HCl), its dosage form (in dextrose injection), and a manufacturing code (PAA118783). However, there is also some text that appears to be garbled and not readable, likely due to errors in the process.*
FDA Label Image

Principal Display Panel (2 mL Ampule Unit Dose Pak Carton)

Principal Display Panel (2 mL Ampule Unit Dose Pak Carton)
This is a product description of Hyperbaric Solution for Spinal Anesthesia, containing 10 Ampuls of 2mL each with bupivacaine hydrochloride in dextrose injection, USP. The solution is manufactured and distributed by Hospira, Inc., and each ampul contains 7.5 mg bupivacaine hydrochloride and 82.5 mg dextrose. The product is sterile and hyperbaric with Marcaine mentioned as its trademark. The packaging comes in unit-dose paks with 19 ampuls and has a unique Easy Break feature for convenience. The dosage instructions recommend adult usage only, and the product should be stored between 20°C to 25°C.*
FDA Label Image

Marcaine 08

Marcaine 08
This is a description of a medication called Marcaine. It is a bupivacaine hydrochloride injection administered through a prescription. It comes in a 2mL dosage with a specific Lot/Exp number. The injection contains 7.5mg of bupivacaine HCl and 82.5mg of dextrose. The name of the company which distributes the medication is Hospira. Marcaine™ is the brand name of this medication.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.